N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation
Open Access
- 25 July 2002
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 40 (3), 437-445
- https://doi.org/10.1016/s0735-1097(02)01986-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Transient increase in plasma brain (b‐type) natriuretic peptide after percutaneous transluminal coronary angioplastyClinical Cardiology, 2000
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Diagnostic Value of B-Type Natriuretic Peptide Concentrations in Patients With Acute Myocardial InfarctionThe American Journal of Cardiology, 1996
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Relationship between Plasma Level of Brain Natriuretic Peptide and Myocardial Infarct SizeJMIR AI, 1994
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Patients admitted to the emergency room with symptoms indicative of acute myocardial infarctionJournal of Internal Medicine, 1991